5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum.

Let's take a closer look at five of this past week's biggest scorchers.


July 20 Weekly Gain My Watchlist
Alnylam Pharmaceuticals (Nasdaq: ALNY  ) $18.74 50% Add
Complete Genomics (Nasdaq: GNOM  ) $12.55 22% Add
Statasys (Nasdaq: SSYS  ) $56.64 19% Add
NetScout (Nasdaq: NTCT  ) $23.20 17% Add
eBay (Nasdaq: EBAY  ) $44.85 12% Add

Source: Barron's.

Alnylam Pharmaceuticals moved higher after its CEO told investors that it's talking to more than one potential partner for its cholesterol drug. The company's injection is targeting patients who don't respond to statins as a way to lower high levels of cholesterol.

Complete Genomics continues to rally on the gene sequencer's new technology that will improve the accuracy and likely reduce the cost of DNA sequencing.

Stratasys shares hit an all-time high last week. Excitement for the prospects of 3-D printing continue to move the few publicly traded players in this niche higher.

Uptime specialist NetScout posted better-than-expected results last week. It also announced that it would be buying Accanto Systems in a move that would beef up its packet flow strategy while adding voice service monitoring to its arsenal of services.

Finally we have eBay coming through with a monster quarter, once again led by booming growth at PayPal.

More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers, there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.

Motley Fool newsletter services have recommended buying shares of eBay and Stratasys. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1952928, ~/Articles/ArticleHandler.aspx, 10/25/2016 5:15:42 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 7 hours ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 4:00 PM
ALNY $37.20 Up +0.53 +1.43%
Alnylam Pharmaceut… CAPS Rating: ***
EBAY $29.22 Up +0.16 +0.55%
eBay CAPS Rating: ****
GNOM.DL $0.00 Down +0.00 +0.00%
Complete Genomics CAPS Rating: **
NTCT $29.75 Up +0.15 +0.51%
NetScout Systems CAPS Rating: **
SSYS $20.06 Up +0.13 +0.65%
Stratasys CAPS Rating: ****